Patent Assignment
Reel/Frame 066501/0995
Assignment of Assignor's Interest
Recorded: 2024-02-20
Pages: 3
Assignor
CANTWELL, MARK J.
Executed: 2019-08-10
Assignee
MEMGEN, LLC
12 GREENWAY PLAZA, SUITE 1100, HOUSTON, TEXAS, 77046
Covered Properties
(2)
Oncolytic Virus or Antigen Presenting Cell Mediated Cancer Therapy Using Type I Interferon and CD40-Ligand
Oncolytic Virus or Antigen Presenting Cell Mediated Cancer Therapy Using Type I Interferon and CD40-Ligand
Application:
62/687,076 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 20, 2024
From: BEG, AMER A.; ANTONIA, SCOTT J.
To: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.
Reel/Frame 066502/0062 →
Change of Name
Feb 20, 2024
From: MEMGEN, LLC
To: MEMGEN, INC.
Reel/Frame 066630/0894 →
License
Aug 12, 2024
From: H. LEE MOFFITT CANCER CTR & RES INST
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 068551/0010 →